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In culture isolated bone marrow mesenchymal stem cells (more precisely termed skeletal stem cells,
SSCs) spontaneously differentiate into fibroblasts, preventing the growth of large numbers of multi-
potent SSCs for use in regenerative medicine. However, the mechanisms that regulate the expansion of
SSCs, while maintaining multipotency and preventing fibroblastic differentiation are poorly understood.
Major hurdles to understanding how the maintenance of SSCs is regulated are (a) SSCs isolated from
bone marrow are heterogeneous populations with different proliferative characteristics and (b) a lack of
tools to investigate SSC number expansion and multipotency. Here, a nanotopographical surface is used
as a tool that permits SSC proliferation while maintaining multipotency. It is demonstrated that retention
of SSC phenotype in culture requires adjustments to the cell cycle that are linked to changes in the
activation of the mitogen activated protein kinases. This demonstrates that biomaterials can offer cross-
SSC culture tools and that the biological processes that determine whether SSCs retain multipotency or
differentiate into fibroblasts are subtle, in terms of biochemical control, but are profound in terms of
determining cell fate.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Adult mesenchymal stem cells are maintained in cellular mi-
croenvironments, termed ‘niches’, in the body. These niches pro-
vide biochemical and physical cues to the cells to prevent undesired
differentiation [1]. We note that more precisely, mesenchymal stem
cells from the bone marrow should be described as skeletal stem
cells (SSCs), differentiating them from mesenchymal cells from
other niche locations [2,3]. These cells hold osteogenic, chondro-
genic, reticular and adipogenic potential and give rise to the
haematopoiesis-supportive stroma [4]..J. Dalby).
r Ltd. This is an open access articleGiven that SSCs can only be isolated in very small numbers,
these cells need to be expanded in culture, away from niche
regulation, to achieve numbers sufficient for regenerative thera-
pies/tissue engineering. Therefore, understanding the control of
SSC self-renewal is equally important as understanding the
mechanism of differentiation. However, to date, the mechanisms
that control SSC self-renewal remain elusive. For example, there
has been only one report that illustrates that SSC adhesion/cyto-
skeletal morphologies are subtly different to that of the fibroblast,
both with intermediate intracellular tension compared to adipo-
cytes and osteoblasts [5,6]. The report highlighted that SSCs dis-
played a slightly lower tension phenotype than fibroblasts [7].
Indeed SSCs and fibroblasts lookmorphologically similar, with SSCs
originally described as fibroblastic progenitors/fibroblast colony
forming units [8,9]. It is therefore likely that these close similaritiesunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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regulation controlling the SSC and fibroblast phenotypes is subtle
even though the phenotypical differences are large. Failure to
control these small differences in culture likely results in the
fibroblastic over-growth typically seen in vitro. Therefore an, as yet,
unmet need remains to develop methods that will enhance SSC
self-renewal (population expansion without loss of multipotency)
[10,11], while preventing spontaneous differentiation of SSCs to
fibroblasts when propagated in cell culture.
Changes in chemistry [5,6,12,13], stiffness [14e16] and nano-
scale topography [17] of cell culture growth surfaces have all been
used to demonstrate that alterations in the physical material
characteristics of the cell growth surface can exert control over SSC
self-renewal in culture; these materials may therefore provide
useful tools to investigate SSC function. Of these, it has been
demonstrated that nanopatterned surfaces can preserve long-term
multipotency of cultured SSCs [10,18]. The surface retains SSC
marker expression and functional multipotency in prolonged cul-
ture and allows retention of marker expression with serial passage
in culture [10,18]. The nanopattern consists of 120 nm diameter
features that are of similar size to fenestrae of sinusoidal capillaries,
where SSCs are thought to reside in the perivascular stem cell niche
[18].
We have used this nanotopographic surface in this report in
order to understand the control of SSC proliferation and note that
when employing such cell-instructive materials, it appears that cell
density can affect SSC morphology and differentiation; e.g. lower
seeding densities promote osteogenesis and higher seeding den-
sities are permissive for adipogenesis [6].
In this report, in the absence of one accepted defined homoge-
nous SSC population, we start with a focus on ensuring our nano-
topographical platform is robust across several subtypes of bone
marrow-derived SSCs. That advanced technologies work as plat-
forms across stem cell populations, so that a technology can be
termed ‘pan-SSC’, for example, is clearly important so that tech-
nologies can translate between labs and find real-world use; yet
this important facet is poorly studied.
We have previously demonstrated the prolonged self-renewal
(marker retention, functional multipotency) of SSC enriched pop-
ulations selected for using the trypsin-resistant cell surface marker
STRO-1 [19e22] as well as with commercially available SSCs
selected for multiple markers [10]. Here, we expand on these
studies to include the widely used enrichment marker, CD271 [23]
(also known as lowaffinity nerve growth factor receptor (LNGFR) or
p75NTR, a member of the low affinity neurotrophin receptor and
tumor necrosis factor receptor superfamily), which is considered to
select SSCs. To optimise SSC self-renewal we first examined
importance of seeding densities to derive a standardised protocol in
order to allow us to determine the importance of cell cycle regu-
lation for SSC maintenance, hypothesising that mitogen activated
protein kinases (MAPKs) would act as a switch from self-renewal to
growth.
2. Materials and methods
2.1. Production of materials
Two master substrates were fabricated on silicon coated with
100 nm polymethylmethacrylate (Elvacite 2041, Lucite Interna-
tional) by electron beam lithography to generate arrays of 120 nm
diameter pits with 300 nm centre-centre spacing and 100 nm
depth in a square (SQ) arrangement, or arrays with an upto± 50 nm
offset of pits for from the centre position creating a near square
(NSQ) arrangement. The silicon substrates were exposed to a 50 kV
electron beam (Vistec VB6 UHR EWF electron beam lithographytool), developed in 1:3 methyl isobutyl ketone: isopropyl alcohol
for 30 s, rinsed in isopropyl alcohol and finally dried in a nitrogen
stream. Nickel dies were made from the patterned resists and
50 nm of Ni-V was sputtered coated. Electroplating was carried out
to a thickness of approx. 300 mm (outsourced to DVDNorden,
Denmark). These nickel shims were cleaned with chloroform for
10e15 min in an ultrasonic bath, subjected to further rinses in
acetone and isopropyl alcohol, and dried once more in gaseous
nitrogen. Polycarbonate (Makrolon® OD2015) substrates were
generated by injection moulding using an Engle Victory 28 hy-
draulic injection moulder. The required nickel inlay corresponding
to a SQ arrangement or NSQ arrangement was inserted prior to
production. Heating to 180 C melted the polycarbonate. A
clamping force of 250 kN was used to imprint onto the surface of
the polycarbonate, with the final dimensions of each substrate
being 24 mm  24 mm. The temperature was allowed to drop to
70 C before separation of the press and polymer. Unpatterned (flat)
substrates were used as controls.
2.2. Atomic force microscopy
AFM experiments were performed with a Nanowizard 3 (JPK,
Berlin, Germany). The images were acquired in tapping mode in air
using silicon cantilevers (FMV from Bruker AFM Probes, Billerica,
MA) with a pyramidal tip, a force constant of 3 N/m, a resonance
frequency of ~75 kHz, and a radius of curvature below 10 nm.
Height, phase and amplitude magnitudes were recorded simulta-
neously for each image.
2.3. Extraction and selection of SSCs
SSC populations were selected by magnetic separation (STRO-1
or CD271) from adherent mononuclear cell fractions from human
bone marrow obtained during routine knee/hip replacement sur-
geries. Briefly, bone marrow aspirate was thinned with basal media
(DMEM supplemented with 10% (v/v) FBS, 1% (v/v) sodium pyru-
vate, 1% (v/v) non-essential amino acids, 1% (v/v) penicillin-
streptomycin, 1% (v/v) L-glutamine, 5% (v/v) Fungizone® ampho-
tericin B), and layered onto Ficoll Paque Premium density gradient
media (GE Healthcare). Following centrifugation at 1513g for
45 min, the intermediate interface of mononuclear cells was
removed and washed with media successively for a total of three
washes. The resulting pellet was transferred into a tissue culture
flask and cells were cultured to near confluence. These were then
detached and selected for the marker CD271 using a human CD271
positive selection kit and magnet (EasySep, Stem Cell Technologies)
as per the manufacturer's instructions. STRO-1þ SSCs were selected
similarly using an in-house STRO-1 antibody (hybridoma courtesy
of Dr Beresford, University of Bath) using a MACS kit from Miltenyi
Biotech. Over the course of this study, cells from 12 donors were
used with each biological test using new cells.
2.4. SSC culture and seeding
All cells were maintained in DMEM basal media (as outlined in
the previous section) at 37 C and 5% CO2. Cell detachment was
performed with 1x TrypLE™ select solution (Gibco, Life Technolo-
gies) for SSC selection and seeding. Even distribution of cells at the
required densities was achieved through the use of a polycarbonate
seeding device (patented by Riehle, Gadegaard and Reynolds,
University of Glasgow, application number PCT/GB2013/052776).
Each sterilised seeding device was placed on top of a substrate, and
a cell suspension at the required concentration was pipetted
through the entry port incorporated into the seeder design. After
several hours, attachment and initial spreading of cells was verified
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addition of media.
2.5. SSC synchronisation
SSCs were seeded onto substrates using seeding devices and
allowed to attach for 24 h. Synchronisation in G0 stage was ach-
ieved by culture in low serum media (0.1% (v/v) FBS with supple-
mented sodium pyruvate, non-essential amino acids, penicillin-
streptomycin, Fungizone-amphotericin B and L-glutamine in
quantities described for maintenance media) for 48 h. Release of
SSCs back into cycle was carried out by replacement of low serum
media with maintenance media containing 10% (v/v) FBS.
2.6. Flow cytometry
Cells corresponding to each patient were washed with PBS,
detached and pooled according to substrate type, and culture
condition (synchronised only/synchronised with release into the
cycle) and then analysed by fluorescence-activated cell sorting
(FACS). Cells were pelleted at 345g, and subjected to further
washing with PBS with 0.1% BSA in ice-cold molecular grade
ethanol (70%) was then added whilst simultaneously agitating the
cells in the vessel. The resuspended cells were held at 4 C for 1 h
for fixation. Propidium iodide staining solution (3.8 mM sodium
citrate, 40 mg/ml propidium iodide in PBS) was added in parallel
with 10 mg/ml RNase A for 3 h at 4 C. Cell cycle distribution was
analysed using a Guava easyCyte™ flow cytometer (Millipore), with
post-analysis using FLOWJO version 10 software (TreeStar, San
Carlos, CA).
2.7. Western blotting
Cells cultured on nanotopographies were detached with
trypsin-versene, washed and pelleted. Protein was extracted with
RIPA buffer (150 mM NaCl, 50 mM Tris-HCl pH 7.5, 1% Triton X-100,
1% deoxycholic acid, 1% SDS) with protease and phosphatase in-
hibitors added (complete mini, EDTA-free protease inhibitor cock-
tail and PhosSTOP phosphatase inhibitor cocktail, Roche), equalized
after performing a Bradford assay (Biorad), and loaded onto a
4e12% polyacrylamide precast gel after addition of loading buffer
(NuPAGE) and heating to 95 C for 5 min. Gels were run at 200 V for
approximately 45 min. Protein transfer was achieved using a PVDF
membrane prepared according to the manufacturer's instructions
(Amersham Bioscience). MOPS SDS running buffer and transfer
buffer were prepared from stock solutions (NuPAGE). The mem-
brane was blocked in 1% (v/v) non-fat milk in PBS for 1 h. Primary
antibodies (rabbit monoclonal anti-osteopontin antibody
(EPR3688) (Abcam), mouse monoclonal anti-alpha-tubulin anti-
body IgG1 (clone B-5-1-2) (Sigma), STRO-1 (sc-4773) (Insight
Biotech) and CD271 (Insight Biotech)) were incubated with the
membrane overnight at suitable dilutions in 1% (v/v) non-fat milk
at 4 C. HRP-linked secondary antibodies (Sigma) were incubated
with the membrane for 1 h (1:5000 dilution in 1% (v/v) non-fat
milk). Detection was achieved using standard chemiluminescence
methods, and visualized using x-ray film.
2.8. Immunostaining
Substrates were washed with PBS and cells were fixed in a so-
lution of 4% paraformaldehyde for 15 min at 37 C. Fixed cells were
briefly permeabilised with permeabilisation buffer (50 mM NaCl,
30 mM sucrose, 3 mM MgCl2$6H2O, 20 mM HEPES, 0.5% v/v Triton
X-100 in PBS, pH 7.2) and blocked in 1% (v/v) BSA in PBS for
15 min at 37 C prior to application of primary antibodies (STRO-1(sc-4773) (Insight Biotech) and CD271 (Insight Biotech)). All anti-
body dilutions were made in 1% (v/v) BSA. Primary antibody in-
cubations took place for 1 h at 37 C at the required dilutions
together with a 1:500 dilution of rhodamine-phalloidin (Molecular
Probes), after which three washes with 0.5% (v/v) PBS-Tween
(PBST) were used to remove any excess. Biotinylated secondary
antibodies (Horse biotinylated anti-mouse IgG (1:50; Vector Lab-
oratories)) were diluted 1:50 and incubated with samples for 1 h at
37 C. Further washes were carried out prior to application of FITC-
conjugated streptavidin probes (Vector Laboratories) diluted 1:50
(30 min at 4 C). After a final three washes, samples were mounted
with immunomount solution containing DAPI to stain cell nuclei
(Vectorshield, Vector Laboratories).
2.9. CellProfiler image analysis
Fluorescence images were analysed using CellProfiler (Broad
Institute, USA) open source cell image analysis software (version
2.1.0), which allowed for the quantification of proteins of interest in
cells after 28 day culture. Multi-step pipelines incorporating input,
processing, threshold and quantification steps allowed the location
of cells to be defined from cell nuclei (DAPI staining), and edges of
cells to be defined with F-actin staining. Integrated intensity
measurements were then obtained for multiple cells within each
image.
2.10. In-cell western (ICW)
Samples fixed in 4% paraformaldehyde were permeabilised as
described for immunostaining and blocked for 1.5 h in Odyssey®
blocking buffer (LI-COR). Primary antibodies (for a protein of in-
terest and a normalizing protein) were diluted in tandem in
blocking buffer and incubated with the samples overnight at 4 C.
These were washed with 0.1% (v/v) PBST three times, and then
incubated with fluorescent-tagged IRdye secondary antibodies
(1:800 dilution) for 1 h. After three further washes in PBST, the
samples were imaged using Odyssey® Sa Infrared Imaging system
(LI-COR). Primary antibodies were all from Cell Signalling as fol-
lows: pERK (phospho-p44/42 MAPK (Erk1/2) (Thr 202/Tyr 204)
(E10) mouse monoclonal antibody (IgG1), ERK1/2 (p44/42 MAPK
(Erk1/2) antibody) rabbit polyclonal, cdc2 rabbit polyclonal anti-
body, p27 kip 1 rabbit polyclonal antibody, E2F-1 rabbit polyclonal
antibody P-Rb (Phospho-Rb (S807/811)), rabbit polyclonal anti-
body, Cyclin D1 (Cyclin D1 (DCS6)) mouse monoclonal antibody
(IgG2a). If a normalizing proteinwas not used, CellTag (LI-COR) was
used to normalize for cell number.
2.11. Next-generation sequencing (RNAseq)
Cells were removed from substrates using trypsin-versene so-
lution followed by cell scraping. Cells in suspension were pelleted
at 345g and washed with PBS to remove residual media. RNA ex-
tractions were performed with the RNeasy extraction kit (Qiagen)
following the manufacturer's instructions. RNA concentrations
were obtained using a Nanodrop ND1000 spectrophotometer
(Thermo Scientific) and samples were submitted to the Glasgow
Polyomics facility (University of Glasgow). A TruSeq® stranded
mRNA low throughput kit (Illumina) was used to process 136 ng of
RNA/sample. A library of template molecules for sequencing was
generated by conversion of mRNA. The steps included poly-A se-
lection, first and second strand cDNA synthesis, cleanup, adenyla-
tion of 30 ends, ligation and cleaning of adapters, PCR amplification
(98 C for 30s, 15 cycles of: 98 C for 10 s, 60 C for 30 s, 72 C for
30 s, 72 C for 5 min) with a final cleanup stage. Cleanup was
achieved using AMPure XP beads (Beckman Coulter). Sequencing
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sequencer). Initial bioinformatics was performed using a Base-
Space® next-generation sequencing platform (Illumina), with dif-
ferential expression data being analysed with Ingenuity Pathway
Analysis (IPA) software (Qiagen).
2.12. Metabolomics
CD271þ SSCs were cultured for 7 days only and STRO-1þ SSCs
were cultured for both 7 and 28 days to expand the analysis further.
Cells werewashedwith cold PBS prior to carrying out the extraction
procedure.Metaboliteswere extracted using cold extraction solvent
(1:3:1 ratio of chloroform:methanol:water). Substrates were
placed, cell side down onto a small volume of solvent, within culture
plates and sealed. These were agitated continuously for 1 h on a
platform shaker at 4 C. The resulting extracts were centrifuged for
3 min at 13,000g to pellet cell debris, and the supernatant kept
at 80 C until ready to proceed with liquid chromatography mass
spectrometry (UltiMate 3000 RSLC with a 20  2.1 mm ZIC-pHILIC
column running at 300 ml/min coupled to an Orbitrap Q-Exactive
(Thermo Fisher). A pooled sample was made to assist with quality
control. The raw mass spectrometry data was processed as previ-
ously described [24], using XCMS for peak picking,MzMatch for pre-
processing (grouping and filtering) and IDEOM for post-processing
(further filtering and identification). A panel of known metabolites
were used as standards, and validated by mass and retention time.
Putative identifications of other metabolites were made based on
data pertaining tomass and predicted retention time. Differences in
metabolome expression and associations to signaling pathways
were further investigated using IPA software (Qiagen).
2.13. Statistics
Unless otherwise stated, statistics were analysed using ANOVA
with Kruskal-Wallis test and Dunn's post-test as we assumed data
did not follow normal distribution.
All raw data can be found at: 10.5525/gla.researchdata.341.
3. Results
3.1. Determining the optimal seeding density for nanotopography-
induced SSC growth
In this report, we use a nanotopographical pattern that supports
SSC self-renewal without promoting differentiation; previously it
was shown to retain SSC phenotype for STRO-1 selected and pur-
chased SSCs (Promocell GmbH) at ~ 3000 cells/cm2 [10]. This is a pit
array, originally patterned using electron beam lithography, con-
sisting of 120 nm diameter nanopits in a square arrangement
(300 nm centre-centre spacing) with 100 nm depth - this is
denoted as SQ (square). After conversion to a metal shim and in-
jection moulding against this shim into polycarbonate, the replicas
have a 120 nm diameter and 80 nm depth feature size with the
300 nm centre-centre spacing retained (Fig. 1a).
To briefly confirm retention of SSC phenotype [10], we used
densitometry of western blots probed with an anti-STRO-1 anti-
body for STRO-1 selected SSCs seeded at 3000 cells/cm2, showing
more STRO-1 is expressed in SSCs on the SQ surface compared to
flat control over a 7 day culture period (Fig. 1b). This supports
previous observations [10] and allows us to move on to trial the
topography with the CD271þ SSC sub-population to better under-
stand the flexibility of the platform.
We therefore repeated this experiment for a longer, 28 day
culture with CD271þ SSCs to provide a more robust phenotypical
analysis. For these experiments, we used the initial seeding densityof 3000 cells/cm2with a typical seeding protocol involving adding a
suspension of SSCs directly into a culture well containing the
substrate. It was found that the topographical effect on mainte-
nance of CD271 expression was negligible with CD271 expression
being lost suggesting fibroblastic overgrowth (data not shown).
This supports the concept that not all proposed SSC populations are
the same and suggests that a high degree of stringency is required
to enable SSC technologies to work as platforms for all SSC sub-
populations [2]. This led us to devise a robust cell seeding protocol,
based on observation that maximising cell-material interaction is
important [5,6,15], that can be used to reproducibly maintain
different SSC sub-populations in cell culture.
As discussed, previous reports have indicated that reducing cell-
cell contact and maximizing cell/material interaction is critical to
gain optimal control of SSC phenotype using biomaterials strategies
[5,6,15]. We therefore employed an in-house fabricated cell seeding
device (Fig. 1c) that ensures even cell distribution and tested a
range of seeding densities; 500, 1000 and 2000 cells/cm2. Varying
cell growth patterns were observed at these different cell densities
(Fig.1d). At 500 cells/cm2 only clonal expansion (intense blue areas)
was observed and, after 28 days, the culture was far from conflu-
ence suggesting that this seeding density was too low (Fig. 1d). At
1000 cells/cm2, both clonal and individual cell expansion was
observed with more of the surface covered in cells (Fig. 1d). At
2000 cells/cm2, however, large amounts of individual cell growth
could be seen and the surfaces were fully confluent (Fig. 1d).
Western blot densitometry (Fig. 1e e cell population observa-
tion from lysate) and CellProfiler [25] (Fig. 1f e allowing per cell
observation) image analysis for CD271 expression after 28 days of
culture indicated that (i) there was negligible difference in
expression at 500 cells/cm2, illustrating that with purely clonal
expansion, substrate type was less important and (ii) at 1000 cells/
cm2 significantly more CD271 was expressed in SSCs on the SQ
surface suggesting that the nanotopography had a strong influence
on SSC self-renewal at this cell density. (iii) At 2000 cells/cm2, no
statistical difference was noted, indicating that cell-cell interaction
was overriding the nanotopographical cues. It was seen that the
CD271þ cells showed normal cell number expansion (i.e. similar to
cells on planar control, Fig. 1g) and proliferation characteristics
(Fig. 1h) at the optimal, 1000 cells/cm2, density. Further, western
blot densitometry of STRO-1 selected SSCs at this concentration
demonstrated retained STRO-1 after 28 day culture (Fig. 1i).
To test the impact of our new seeding protocol on CD271þ SSCs
in culture, metabolomics analysis was carried out. Here, we use
analysis of metabolites bymass spectrometry after 7 days of culture
for CD271þ SSCs cultured on SQ vs flat control with a seeding
density of 1000 cells/cm2 and Ingenuity Pathway Analysis (IPA) to
indicate pathways where metabolomic changes link into cellular
biochemistry. This analysis was chosen to see if we could infer
MAPK regulation without ignoring other possibilities through se-
lection bias. Indeed, the top three networks selected were all
related to cell proliferation and tied into p38 MAPK, extracellular
signal related kinase, ERK 1/2 (MAPKs) and Akt (a serine/threonine-
specific protein kinase) signalling hubs with contributions largely
from amino acid biosynthesis, glycolysis and nucleotide biosyn-
thesis, i.e. protein and energy metabolite pathways as would be
expected to be implicated in control of SSC phenotype [7,26]
(Fig. 2).
This provides further confidence that the SQ topography is
exerting its self-renewal effect during proliferation in the more cell
number sensitive CD271þ SSC population and that our optimised
cell seeding protocol has a significant effect on retaining SSC
phenotype during expansion in extended cell culture. Thus, we can
be satisfied that our platform is valid for multiple SSC sub-
populations after adjusting seeding conditions.
Fig. 1. Determining the optimal seeding density for SQ nanotopography. (a) AFM image representative of our self-renewal promoting nanotopographical pattern; the surface of a SQ
substrate produced by injection moulding. Dark regions indicate the location of the pits. The graph to the right of the images shows the depth and spacing of the features. Scale bar:
1 mm. (b) STRO-1 protein levels in SSCs cultured on SQ nanotopographies using a conventional seeding method (suspension method at ~ 3000 cells/cm2). Retention of STRO-1 was
demonstrated with western blot densitometry after 7 days of culture. Results represent relative density of STRO-1 protein normalised to GAPDH, expressed in arbitrary units (a.u.).
(c) Schematic of a seeding device for even cell distribution. Each sterile seeder (produced in-house) was placed on top of the polycarbonate substrate. (d) Full substrate images of
SSCs stained with Coomassie Blue after 28 days culture. Distinct growth patterns were observed that appeared associated with initial seeding density. At the low and mid-density
conditions (500 cells/cm2 and 1000 cells/cm2 respectively), growth of cells were mostly confined to colonies (clonal growth), whereas at the highest seeding density (2000 cells/
cm2), cells spread throughout the surface (fibroblastic growth) reaching full confluence. These observations were not restricted to the SQ nanotopography, and was thus a substrate-
independent effect. Representative images shown (n ¼ 3). (e) Percentage of CD271 protein expression at each tested seeding density as a function of the flat control. The data
summarises western blot densitometry results (CD721 normalised to GAPDH) following 28 days culture of CD271þ SSCs. It can be seen that the highest CD271 stem cell marker
levels are found when utilising an initial seeding density of 1000 cells/cm2. Each of the other densities tested resulted in a lower percentage of CD271. (f) Levels of CD271 protein in
individual cells after 28 day culture were assessed across different seeding densities to provide detailed analysis using CellProfiler image analysis. This involved quantifying in-
tegrated intensity levels for each cell across multiple fluorescence images (>40). The data reflects the trends observed with western blotting, in that 1000 cells/cm2 gave the highest
CD271 readings on SQ relative to flat. At 500 cells/cm2, CD271 was similar across the two substrate types whereas at 2000 cells/cm2, CD271 was not effectively retained on SQ.
*p < 0.05, ANOVA (mean ± SEM, a.u. ¼ arbitrary units). (g) Assessment of growth (mean nuclei count ± SEM) showed that CD271þ SSCs increased in number on SQ as time
progressed (n ¼ 3). (h) BrdU staining (mean % BrdU positive nuclei ± SEM) indicated a comparable degree of proliferation between flat and SQ (n ¼ 3). (i) Western blot densitometry
(STRO-1 normalised to GAPDH) showing that by seeding STRO-1þ SSCs at 1000 cells/cm2 on SQ, the effect of stem cell marker retention was reproducible. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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self-renewal and osteogenesis
Satisfied that the nanotopography exerts self-renewal effects on
multiple SSC sub-populations, we moved back to use of STRO-1populations, as are routinely used in our labs, for investigation of
biological mechanism. In the introduction, we hypothesised that
self-renewing SSCs will undergo changes in cell cycle regulation,
potentially through changes in MAPK signalling. To study this we
examined expression levels and activation of mediators of cell cycle
Fig. 2. Linking changes in the metabolome to biochemical networks. MS-
metabolomics analysis of CD271þ SSCs (7 day culture) highlighted that the top net-
works on SQ with reference to flat controls had associations with (a) p38 MAPK (b)
ERK 1/2 and (c) Akt. Contributions to these signalling hubs came largely from me-
tabolites involved in amino acid biosynthesis, glycolysis and nucleotide biosynthesis.
Network maps were generated using IPA (n ¼ 6).
L.C.Y. Lee et al. / Biomaterials 116 (2017) 10e20 15progression. In this section, we introduce an extra control in
addition to the flat surfaces. We employ our near-square (NSQ)
surface as a positive osteo specific differentiation control [7,17,27].
This topography is similar to the SQ surface but with an up to
±50 nm offset from the centre position (Fig. 3a). Briefly, the surface
was tested for osteogenesis by western blot densitometry for
osteopontin (OPN, a bone specific marker) after 28 days of STRO-1
culture (seeded at 1000 cells/cm2) and showed increased expres-
sion compared to SSCs on flat control or the SQ pattern (Fig. 3b)
confirming published data [7,17,27]. Use of NSQ allowed us to
compare and contrast growth between three distinct groups: SSC
self-renewal on SQ, typical culture phenotypical drift during pro-
liferation on flat controls and targeted osteoblastic differentiation
on NSQ.
Protein-level quantification of expression and activation of a
range of cell cycle-related proteins was next undertaken (Fig. 3c).
Following serum starvation to hold cells at G0/G1 [28e30] (SSCs
were seeded for 24 h in 10% FBS containing media before switching
to 0.1% FBS for a further 48 h), release of synchronised SSCs back
into the cycle (reversion to 10% FBS containing media) for 1, 4 and
24 h, revealed significant differences in levels of progression reg-
ulatory proteins including positive regulators of cycle progression -
E2F transcription factor 1 (E2F-1) and cyclin D1 as well as negative
regulators - phosphorylated retinoblastoma protein (pRB) and
p27kip1.
Increased phosphorylated retinoblastoma protein (pRB) levels
were consistently observed in cells on NSQ while levels remained
low on both the control and SQ. E2F-1 protein levels were seen to
reduce at later time-points on NSQ (Fig. 3c). Levels of the cyclin-
dependent kinase inhibitor, p27kip1, were also noted to be signifi-
cantly lower in cells on NSQ (Fig. 3c) in comparison to cells on flat
control and SQ. For SSCs on SQ, the CDK6 protein level was seen to
be elevated and cyclin D1 levels lowered compared to SSCs on
control or NSQ (Fig. 3c).
As the majority of changes in cell cycle proteins between sur-
faces were observed after 24 h of progression from re-entering the
cell cycle, we performed flow cytometry for SSCs cultured on SQ
compared to SSCs on flat control at this time point. Analysis
revealed an increased trend for SSCs to remain in G0/G1 when
cultured on SQ (from 53.6% on flat to 60.2% on SQ - Fig. 3d and
Supplementary Fig. 1 for larger view of the flow analysis).
Our data also shows changes in ERK 1/2 activation (increased
phosphorylation on both surfaces) and after 0 and 24 h with
decreased activation on NSQ (Fig. 3c).
3.3. Transcriptional analysis of SSC self-renewal
Results demonstrate that t24 h post synchronisation was asso-
ciated with significant changes in the expression of cell cycle reg-
ulatory proteins (Fig. 3c). We therefore performed next generation
sequencing (RNAseq) transcriptional analysis after 24 h to further
determine the full range of genes that are regulated during the
transition from cell cycle to differentiation. We compared SSCs on
SQ (and in supplementary dialogue NSQ) to those on flat control
and identified pathways that included hits from cell cycle analysis
(Fig. 3) in order to further identify regulators of SSC self-renewal. To
confirm and expand this transcriptional analysis, untargeted
metabolite analysis using mass spectrometry was also performed
after 7 and 28 days of culture (we chose longer, un-synchronised
time points for metabolomic analysis as short term metabolite
abundance changes can be small) [27].
Two gene networks were identified by RNAseq that included
hits for cell cycle regulators. Firstly, Fig. 4a implicates cell adhesion
in the negative regulation of ERK 1/2 in SSCs on SQ compared to flat
control. Measurement of total ERK 1/2 protein levels showed that
Fig. 3. Cell cycle regulation on nanotopography. (a) AFM image representative of the surface of our osteogenic differentiation nanopattern, NSQ. Dark regions indicate the location of
the pits, which have a degree of offset (±50 nm) in comparison to the ordered SQ nanotopography. The graph to the right of the images gives an indication of the pit depth and
spacing. Scale bar: 1 mm. (b) Verification of the effects of NSQ on SSCs was tested by culturing CD271þ SSCs for 28 days and western blot analysis. Results shown are relative OPN
protein levels normalised to alpha tubulin (expressed in a.u.). It can be seen that OPN is higher on NSQ, suggesting that osteogenesis is taking place as expected. (c) Synchronised
and subsequently released SSCs were assessed for changes in levels of cell cycle-related proteins. Graphs represent mean fluorescence intensity (a.u.) values ± SEM for the protein of
interest, normalised to either total protein (pRb to total Rb, pERK to total ERK) or GAPDH (n  4). Significant changes were observed in cyclin D1, E2F-1, pRb, pERK and CDK6,
suggesting that cell cycle regulation is altered by nanotopography. *p < 0.05, **p < 0.01, by ANOVA. (d) Flow cytometry data illustrating an increased preponderance for SSCs to be in
G0/G1 phase on SQ (n ¼ 2).
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control (Fig. 4a inset). However, this did recover when cells were
released back into the cell cycle (Fig. 4a inset). We note that the
MAPK Jnk was a more highly ranked network for SSCs on NSQ and
that Jnk was positively regulated (Supplementary Fig. 2). The
amino-acidmetabolite network shown in Fig. 2b indicated negative
regulation of ERK 1/2 was likely; the same network for SSCs on NSQ
predicted positive regulation (Supplementary Fig. 3).
RNAseq analysis indicates cyclin D1, cyclin B and cdc2 (cell di-
vision cycle 2 or cyclin dependant kinase 1, CDK1), positive regu-
lators of cell cycle progression, become down-regulated on SQ
(Fig. 4b). The same analysis also indicated down-regulation of a
number of negative cell cycle regulators - p21Cip1, p19INK4D and
p18INK4C) in SSC on SQ (Fig. 4b). This transcription-level repression
of cyclin D1 in SSCs on SQwas also reflected at protein level (Fig. 3c)
while we note that the down-regulation of cdc2 seen in Fig. 4b was
not seen at protein level (levels were unchanged, Fig. 3c).
Canonical pathway analysis revealed that a number of signifi-
cant pathways are implicated in cell cycle control, such as G1/S
checkpoint regulation, cyclins in cell cycle regulation, G2/M
checkpoint regulation and mitotic role of polo-like kinase e it is
noteworthy that these have balanced up-and down-regulation(Fig. 4c e denoted by *). For SSCs on NSQ, many more pathways
were highlighted as significant (Supplementary Fig. 4). Again, the
same cell cycle pathways were noted and, again, they were shown
to have a balance of up and down-regulation (Supplementary
Fig. 4). Further, components of adhesion-related signalling pro-
cesses including RhoA, integrin, Rac, and actin cytoskeleton sig-
nalling were implicated as differentially regulated compared to flat
control in cells on SQ (Fig. 4c e denoted by x) and NSQ
(Supplementary Fig. 4).
3.4. Metabolomic analysis of SSC self-renewal
As has been described, changes in MAPKs will be driven by
changes in the levels of metabolites [7]. Here, we move to confirm
and expand on data in Fig. 2 (derived from CD271þ SSCs) with
STRO-1þ SSC populations after 7 and 28 days of culture. Analysis of
metabolites highlighted an amino acid network common to SQ and
NSQ (Fig. 5) linking to ERK1/2. The networks are revealing as on SQ
at 7 days they showed strong down-regulation of metabolites
linking to ERK 1/2 (Fig. 5a) while on NSQ a number of up-
regulations were apparent (Fig. 5b). By day 28, while there were
a number of up-regulations now apparent in SSCs on SQ (Fig. 5c), all
Fig. 4. Mechanisms underlying SQ induced self-renewal. (a) Graph (inset) shows in cell western results for total ERK 1/2 for SQ (red) and flat (blue) across 0, 1, 4 and 24 h. ERK 1/2
was consistently lower on SQ when compared to the control (significantly at t ¼ 0), and decreased progressively when moving through the cell cycle. ***p < 0.001, t-test. RNAseq
analysis generated a network in IPA that links ERK 1/2 and adhesion-based signalling on SQ 24 h following release into the cycle after synchronisation. ERK 1/2 was also indicated to
be down-regulated here. (b) Several genes associated with cell cycle progression (CDK1 (cdc2), cyclin B, cyclin D1) and those related to cycle repression (p18INK4C, p19INK4D and
p21cip1) were up-regulated (green) on in cells on SQ (arrows point to all named genes). (c) Canonical pathway analysis underlines differential regulation of cell cycle (denoted as *)
and adhesion (denoted as x) in cells on the SQ topography compared to those on control. A general trend of down-regulation can be observed across the majority of signalling
groups for cells on on SQ. Note that only pathways with p < 0.05 are shown. A two-fold change cut-off was applied for RNAseq data (n ¼ 3). (For interpretation of the references to
colour in this figure legend, the reader is referred to the web version of this article.)
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(Fig. 5d).4. Discussion
The current study examined the importance of cell cycle control
in the regulation of SSC self-renewal and multi-potentiality. First,
we noted that not all SSCs are the same, for examplewhile STRO-1þ
SSCs retain STRO-1 expression on the SQ surface when seeded at
high or low density, CD271þ cells required a stringent, low-density,
seeding protocol to allow CD271 retention during cell expansion.
That SSCs are heterogeneous is not a new observation, but clearly
important when considering technologies that need to spandifferent labs with different isolation protocols or indeed that uti-
lise commercially available SSCs. In our hands, CD271þ SSCs were
less sensitive to the surfaces than STRO-1þ SSCs. To achieve self-
renewal control of both SSC sub-populations we note that the
seeding density is critical. At sub-optimal cell densities, where
purely clonal growth is seen irrespective of the surface the SSCs are
cultured on, underlying topography is not important. If the density
is too high, then uncontrolled growth and phenotypical drift is
noted. However, there is a ‘Goldilocks’ zone where the nano-
topography can provide strong influence over the self-renewal of
CD271 isolated cells and the STRO-1 isolated cells.
We hypothesised that MAPKs may act as the decision switch
between self-renewal and differentiation. Differences in ERK 1/2
Fig. 5. Comparison of amino acid networks generated by metabolic analysis. A common amino acid network with associations to ERK 1/2 was identified on SQ and NSQ in STRO-1þ
SSCs after 7 and 28 days of culture. (a) After 7 days, a high degree of down-regulation (green) was apparent on SQ with (b) some up-regulations (red) being observed after 28 days
(c) at 7 days on NSQ more amino acids were up-regulated (red) than SQ. (d) this trend became more obvious after 28 days, where the majority of amino acids linked to ERK 1/2 were
up-regulated (n ¼ 3). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
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control. This was supported transcriptionally, where adhesion sig-
nalling linked to ERK 1/2 and changes in integrin, G-protein and
cytoskeletal signalling were noted. This is in agreement with re-
ports on adhesion and ERK 1/2 being important in osteogenesis
[5,6,15,17]. Further, using bioinformatics to link metabolite data to
biochemical pathways allows suggestion that SSCs were still
‘working’ to repress ERK 1/2 signalling on SQ even after a month of
culture. However, on NSQ, the metabolite signals into the ERK 1/2
cascade were highly up-regulated and, as noted, up-regulation of
ERK 1/2 is widely observed in osteogenesis [5,7,31].
Investigating cell cycle, increased pRB levels were noted in SSCs
on NSQ, suggesting early cell-cycle repression at the transition
between G1 and S phase as RB phosphorylation blocks S phase
entry. Accumulation of pRB protein may be beneficial during the
switch from proliferation to differentiation as pRb has been re-
ported to interact with transcription factors specific to osteogenesis
and adipogenesis (Runx2 and PPARg) [32]. It can therefore bepostulated that higher levels of pRbmay influence the promotion of
osteogenesis. The E2F-1 transcription factor, which acts as a mo-
lecular ‘switch’ between proliferation and differentiation [33] can
bind pRB. Unbound, E2F-1 promotes G1 to S phase transition.
However, when the pRB/E2F-1 complex is formed the G1 to S phase
transition is inhibited [34]. It is thus noteworthy that the decrease
in E2F-1 protein levels at later time-points on NSQ thus correlates
with the observed increases in pRB levels.
Down-regulation of p27kip1 in SSCs on NSQ indicates that the
SSCs are not completely stopping cell cycle progression as targeted
osteogenic differentiation is induced by NSQ. Rather, this may
suggest a more subtle mechanism to slow cell growth, as it typically
seen with osteoblastic differentiation, with some negative regula-
tors up-regulated (e.g. pRB) and others down-regulated (e.g.
p27kip1).
For self-renewing SSCs on SQ, cell cycle regulationwas also seen
to change. High CDK6 protein levels in HSCs correlates with exit of
quiescence following mitogenic stimulation [35] and, interestingly,
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osteoblast differentiation [36]. Our data shows that CDK6 levels
were elevated on SQ and while we can postulate that this increase
in CDK6may be involved in preventing differentiation, we note that
the observed increase was modest and we therefore hypothesise
that an intermediate level of CDK6 is important for self-renewal,
allowing the SSCs to increase in number steadily, but not to un-
dergo differentiation.
Repression of cyclin D1 in SSCs on SQ concurs with the noted
increase in G1 preponderance as it is required to form a complex
with e.g. cdc2 (cell division cycle 2) to drive cell cycle progression.
We note that levels of cdc2 (CDK1) were relatively similar on all
surfaces (Fig. 3c).
Together, our protein-level data suggests that different modes of
cell cycle control select between self-renewal (SQ) and active dif-
ferentiation (NSQ) in SSCs.While self-renewing SSCs appear to hold
in G1 via a cdc2 dependant mechanism, osteo-committed cells are
shown to repress S phase transition via p27kip1. Further, changes in
ERK1/2 regulation in SSCs on the surfaces helps identify this MAPK
as a potential cell-cycle regulating switch for self-renewal and
differentiation in SSCs. Supported by RNAseq and metabolomics
data this ties in with the literature describing ERK and Jnk up-
regulation/activation as being important in osteogenesis from
SSCs [5e7,31].
RNAseq data helps support hypotheses drawn from protein-
level data. Cyclin D1, cyclin B and cdc2 (CDK1) are involved in cell
cycle regulation during G1 and G2/M phases [37] and have been
reported to help regulate pluripotency in human embryonic/
induced pluripotent stem cells [38] and were down-regulated in
SSCs on SQ. Negative regulators of the cell cycle, p21Cip1, p19INK4D
and p18INK4C), were also down-regulated on SQ, which suggests
that cell cycle progression is occurring on this surface (i.e. inhibitors
of the cell cycle are not preventing SSC proliferation) but that the
cycle is differentially regulated. Again, negative regulators, such as
p27kip1, are thought to be important for pluripotency of human
embryonic stem cells (ESCs) [39] although it should be noted that
ESCs have short G1 phases [40e42].
Transcript analysis also implicated adhesion and cytoskeleton as
important in self-renewal (SQ) and osteocommitment (NSQ). This is
in line with studies proposing that self-renewing stem cells
maintain an intermediate tension phenotype [43], in contrast with
the requirement of high tension and well spread morphology in
osteoblasts and low tension and rounded/less pronounced cyto-
skeletal changes for adipogenesis [44,45].
Observations of the levels of cell cycle control proteins provided
evidence that on the SQ, self-renewal promoting, substrate, SSCs
differentially regulate cell cycle progression with cycle control
becoming tightly regulated and a greater preponderance for SSCs
remaining in G1. This is in disagreement with reports on pluripo-
tent stem cells [40e42], but in agreement with reports on adult
neural stem cells and suggests cell cycle control [46].
This report helps to highlight differences between in vitro
renewing SSCs and SSC populations undergoing typical pheno-
typical drift during culture. While the difference between adipo-
cytes and osteoblasts are large, the differences between SSCs and
fibroblasts are subtle but, nonetheless, important. Previous work
has highlighted that a slight reduction in adhesion and intracellular
tension are required for the SSC phenotype [7]. Our metabolomic
analysis showed commonality of mechanism for CD271 and STRO-1
enriched populations with MAPKs, most notably, ERK 1/2 being a
target of metabolite control; RNAseq and protein-level data
confirmed this. Furthermore, RNAseq transcriptomics data indi-
cated ERK1/2 regulation had contributions from cell adhesion
signalling.
Together, this data indicates SSC phenotype is regulated byadhesion, which is a reasonable assumption given that SSCs adhere
to the extracellular matrix within their in vivo niche. Downstream
of the cell adhesions, we hypothesise that ERK1/2 helps regulate
SSC cell cycle control to retain stem cell phenotype.
SSCs possess the ability to both self-renew and differentiate,
with the maintenance of self-renewal being prominently observed
in their niche environment. As our understanding of differentiation
mechanisms has progressed, the study of self-renewal has been
somewhat limited in comparison. However, the ability to control
self-renewal using nanomaterials provides new hopes for SSCs in
therapeutic application through the ability to continuously expand
SSCs and demonstrates the large potential of nanomaterials as tools
for use in cell biology.
5. Conclusions
The study demonstrates that cell seeding is of great importance
in SSC based experiments. Different labs have different seeding
protocols and cell counting suffers inherent variability. As SSC
directing materials become more widely researched it is important
that labs ensure that their seeding protocol is adapted to get best
results from the materials they are generating or adopting.
The study shows that a MAPK switch driving changes in cell
cycle regulation to control phenotype likely controls SSC self-
renewal and differentiation. This appears sensible as the SSC
niche control quiescence, symmetrical and asymmetrical self-
renewal to respond to regenerative demand.
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